12/2: StreetInsider.com Unusual 11 Afternoon Movers:

Inspire Pharm (Nasdaq: ISPH) 33.92% LOWER; the FDA said Diquafosol studies failed to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE